Key points
- Revenue increased by 10% to $21.4 million
- EBITDA turned positive at $0.6 million
- Branded B2C revenue grew 101% year-on-year
- OzSun launched in Germany and Poland
- International expansion gaining commercial validation
Full summary
ECS Botanics Holdings Ltd reported a 10% increase in revenue to $21.4 million for the year ended 30 June 2026, with EBITDA turning positive at $0.6 million compared to a loss of $5.2 million in FY2025. Branded B2C revenue surged 101% year-on-year to $13.7 million, representing 65% of total revenue. The company delivered four consecutive quarters of positive operating cash flow, improving by $5.6 million to $0.5 million. International expansion saw OzSun launch in Germany and Poland, with initial shipments selling out and repeat orders received. The company also launched several new products, including AVANI AVA and Terphogz Gelanoidz #20, further diversifying its portfolio.
Outlook
ECS Botanics plans to leverage its established platform to pursue growth opportunities in FY2027, focusing on growing branded B2C sales, scaling OzSun in Germany, increasing export revenue, and expanding its AVANI and Terphogz portfolios.